Patient radiation doses received during interventional radiological pr
ocedures can be significant. To aid in the establishment of reference
dose levels, a patient dose survey has been conducted of such procedur
es. A total of 288 non-coronary procedures (177 classified as diagnost
ic and 111 as therapeutic) were accrued into the study. For each proce
dure, the fluoroscopy screening time and the fluoroscopic and digital
radiographic dose-area products were recorded in a computer database.
For example, median dose-area product values (due to fluoroscopy and d
igital radiography combined) of 24.2, 27.9, 69.6 and 74.7 Gy cm(2) wer
e obtained for nephrostomy, biliary stent removal/insertion, cerebral
angiography and percutaneous transhepatic cholangiography procedures.
While the effective dose is not an accurate measure of patient risk, i
t is convenient for comparing the radiological risks associated with v
arious procedures. Effective doses were estimated from the total dose-
area products. The respective median estimated effective dose values f
or the four procedures noted above were 3.9, 4.5, 7.0 and 12.0 mSv. Wh
ile an infrequently performed procedure at this institution (n=4 durin
g this survey), the transjugular intrahepatic portosystemic shunt (TIP
S) procedure had the greatest median dose-area product and effective d
ose values: 347 Gy cm(2) and 55.5 mSv, respectively. Excluding the ext
reme case of TIPS, it was found that among commonly-performed procedur
es, those that are categorized as therapeutic do not necessarily prese
nt a statistically significant greater radiation risk than those which
are diagnostic. Comparisons between dose-area product values obtained
from this study are made with data from other interventional radiolog
y patient dose surveys and reasons for some differences noted are disc
ussed.